Mechanistically, LINC00240 enhances the binding of DDX21 to its novel deubiquitinating enzyme USP21, leading to deubiquitination of DDX21 and avoiding its degradation by the ubiquitin-proteasome system, which enhances the stability of DDX21 and promotes the progression of GC [57]. The gene discussed is DDX21; the disease is gastric cancer.